Fingerprint
Dive into the research topics of 'Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: What is the impact of JAK2 inhibitor therapy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: What is the impact of JAK2 inhibitor therapy?
Raoul Tibes, Ruben A. Mesa
Research output: Contribution to journal › Review article › peer-review
9
Scopus
citations